These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19779497)
1. p73 is essential for vitamin D-mediated osteoblastic differentiation. Kommagani R; Whitlatch A; Leonard MK; Kadakia MP Cell Death Differ; 2010 Mar; 17(3):398-407. PubMed ID: 19779497 [TBL] [Abstract][Full Text] [Related]
2. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage. Kommagani R; Payal V; Kadakia MP J Biol Chem; 2007 Oct; 282(41):29847-54. PubMed ID: 17716971 [TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling. Kaiser MF; Heider U; Mieth M; Zang C; von Metzler I; Sezer O Eur J Haematol; 2013 Apr; 90(4):263-72. PubMed ID: 23311753 [TBL] [Abstract][Full Text] [Related]
5. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799 [TBL] [Abstract][Full Text] [Related]
6. 1α, 25-Dihydroxyvitamin D₃ and the vitamin D receptor regulates ΔNp63α levels and keratinocyte proliferation. Hill NT; Zhang J; Leonard MK; Lee M; Shamma HN; Kadakia M Cell Death Dis; 2015 Jun; 6(6):e1781. PubMed ID: 26068789 [TBL] [Abstract][Full Text] [Related]
7. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851 [TBL] [Abstract][Full Text] [Related]
8. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492 [TBL] [Abstract][Full Text] [Related]
9. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Guo B; Aslam F; van Wijnen AJ; Roberts SG; Frenkel B; Green MR; DeLuca H; Lian JB; Stein GS; Stein JL Proc Natl Acad Sci U S A; 1997 Jan; 94(1):121-6. PubMed ID: 8990171 [TBL] [Abstract][Full Text] [Related]
10. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Lau LM; Nugent JK; Zhao X; Irwin MS Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533 [TBL] [Abstract][Full Text] [Related]
11. Dystrobrevin alpha gene is a direct target of the vitamin D receptor in muscle. Tsoumpra MK; Sawatsubashi S; Imamura M; Fukumoto S; Takeda S; Matsumoto T; Aoki Y J Mol Endocrinol; 2020 Apr; 64(3):195-208. PubMed ID: 31940280 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320 [TBL] [Abstract][Full Text] [Related]
13. p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling. Fernandez-Alonso R; Martin-Lopez M; Gonzalez-Cano L; Garcia S; Castrillo F; Diez-Prieto I; Fernandez-Corona A; Lorenzo-Marcos ME; Li X; Claesson-Welsh L; Marques MM; Marin MC Cell Death Differ; 2015 Aug; 22(8):1287-99. PubMed ID: 25571973 [TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Ma Y; Yu WD; Hershberger PA; Flynn G; Kong RX; Trump DL; Johnson CS Mol Cancer Ther; 2008 Sep; 7(9):3047-55. PubMed ID: 18790784 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093). Ryhänen S; Jääskeläinen T; Saarela JT; Mäenpää PH J Cell Biochem; 1998 Sep; 70(3):414-24. PubMed ID: 9706878 [TBL] [Abstract][Full Text] [Related]
16. Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73. Huang V; Lu X; Jiang Y; Wang JY BMC Biol; 2009 Jun; 7():35. PubMed ID: 19558638 [TBL] [Abstract][Full Text] [Related]
17. Variations in vitamin D receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells. Shakoori AR; van Wijnen AJ; Bortell R; Owen TA; Stein JL; Lian JB; Stein GS J Cell Biochem; 1994 Jun; 55(2):218-29. PubMed ID: 8089197 [TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73. Liang W; Xia H; Li J; Chunhua Zhao R J Pediatr Hematol Oncol; 2012 Mar; 34(2):108-15. PubMed ID: 22278203 [TBL] [Abstract][Full Text] [Related]
19. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination. Wu H; Zeinab RA; Flores ER; Leng RP Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467 [TBL] [Abstract][Full Text] [Related]
20. The function of vitamin D receptor in vitamin D action. Kato S J Biochem; 2000 May; 127(5):717-22. PubMed ID: 10788778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]